PRESS RELEASES
NEWS
23/03/2023
23/03/2023
Unlocking the Potential of Biotechnology Innovation for Patients
16/03/2023
16/03/2023
Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future
07/03/2023
07/03/2023
Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders
06/03/2023
06/03/2023
Can the Pharmaceutical Strategy Deliver for Europe?
03/03/2023
03/03/2023
For The Love of Science
01/03/2023
01/03/2023
Vlad Olteanu new Healthcare Public Affairs Director at EuropaBio
28/02/2023
28/02/2023
How do we live in a bioeconomy? EuropaBio at the Swedish EU Council Presidency conference
28/02/2023
28/02/2023
Helping Europe Deliver for Rare Disease Patients
24/02/2023
24/02/2023
“Life is like a box of chocolates, you never know what you’ll get”
23/02/2023
23/02/2023
EuropaBio Response to Public Consultation on Horizon Europe – interim evaluation
17/02/2023
17/02/2023
Do your best and do not forget, there will always be a next time!
17/02/2023
17/02/2023
Inter-association letter to raise our concern about the proposed definition of “natural polymers” in the REACH restriction of microplastics
10/02/2023
10/02/2023
Leave no pathway unexplored
06/02/2023
06/02/2023
Delivering Europe’s ambitions in rare disease
01/02/2023
01/02/2023
Joint Statement: The Data Act is a leap into the unknown
31/01/2023
31/01/2023
EuropaBio’s 2022 Patient BioForum sets out recommendations to address the challenges of patients with unmet medical needs and calls for multi-stakeholder approach
17/01/2023
17/01/2023
EuropaBio launches SME BioForum in Rare Diseases
17/01/2023
17/01/2023
EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform
16/01/2023
16/01/2023
SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins
19/12/2022
19/12/2022
EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe
19/12/2022
19/12/2022
The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry
13/12/2022
13/12/2022
EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor
13/12/2022
13/12/2022
EuropaBio sat down with new member SenseUp, to find out about the natural evolution approach for novel protein and RNA products
13/12/2022
13/12/2022
SenseUp joins EuropaBio: leveraging the power of bio-tech for sustainable and commercially viable solutions
08/12/2022
08/12/2022
‘Rare Disease Moonshot’ – Scaling-up public-private partnerships to accelerate research into world’s rarest diseases
02/12/2022
02/12/2022
EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach
30/11/2022
30/11/2022
EuropaBio presents EFIB Vilnius Statement to European policymakers
28/11/2022
28/11/2022
Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework
25/11/2022
25/11/2022
The time to act is now! Biotechnology for global transformation
23/11/2022
23/11/2022
Innovation, Investment, and Excellence for Healthcare Biotechnology: Achieving a competitive environment in Europe | EuropaBio Healthcare BioForum, October 2022
16/11/2022
16/11/2022
Policy Proposal for New Genomic Techniques – Joint Letter to the EU Vice-President Frans Timmermans and the EU Commissioner Stella Kyriakides
14/11/2022
14/11/2022
A new initiative for building a more competitive Europe: EuropaBio announces Biomanufacturing Platform
11/11/2022
11/11/2022
The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?
28/10/2022
28/10/2022
Europe’s potential in advanced Biomanufacturing at the centre of EFIB 2022 discussions
24/10/2022
24/10/2022
European Biotech Week 2022: Bringing Biotech to Local Communities
20/10/2022
20/10/2022
Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe
19/10/2022
19/10/2022
#EFIB2022:  Industrial biotechnology community comes together in Vilnius next week
11/10/2022
11/10/2022
Factsheet – Vision for Europe: Excellence
11/10/2022
11/10/2022
Factsheet – Vision for Europe: Investment
11/10/2022
11/10/2022
Factsheet – Vision for Europe: Innovation
06/10/2022
06/10/2022
EuropaBio celebrates its inaugural Healthcare BioForum
03/10/2022
03/10/2022
Vision for Europe: Innovation, Investment, Excellence | Claire Skentelbery, EuropaBio
30/09/2022
30/09/2022
Collaboration, expertise, and infrastructure: key ingredients for gene therapy to thrive in Europe
25/09/2022
25/09/2022
European Biotech Week 2022 starts today!
21/09/2022
21/09/2022
Vision for Europe:Innovation, Investment, Excellence | Yordan Aleksandrov, Pfizer
21/09/2022
21/09/2022
Vision for Europe: Innovation, Investment, Excellence | Tineke Van hooland, bio.be/essenscia
21/09/2022
21/09/2022
Vision for Europe: Innovation, Investment, Excellence | Thomas Bols, PTC Therapeutics
21/09/2022
21/09/2022
EuropaBio sat down with new Member Freget Glaser & Associés, to learn more about investment and growth opportunities for European biotechnology
21/09/2022
21/09/2022
Freget Glaser & Associés joins EuropaBio: steering the innovation potential through a secure legal framework
21/09/2022
21/09/2022
EuropaBio sat down with new Member Bon Vivant, to learn more about the future of alternative dairy proteins
21/09/2022
21/09/2022
Bon Vivant joins EuropaBio: dairy products with a lower impact on human health, animals and planet
21/09/2022
21/09/2022
Factsheet – Sustainable Investment and the EU Bioeconomy
19/09/2022
19/09/2022
Biotech SMEs are the heart of Europe’s healthcare ecosystem – hear their voice.
14/09/2022
14/09/2022
Registration is open to the main events of the 10th edition of the European Biotech Week
09/09/2022
09/09/2022
The Essential Role of Enzymes | The unintended impact of the REACH revision on Enzymes – and consequences for EU Green Deal Objectives
08/09/2022
08/09/2022
The role of enzymes as key enablers in the green transition and in enabling the European Commission’s sustainability ambitions in the EU Taxonomy and Sustainable Finance
07/09/2022
07/09/2022
EuropaBio response to the public consultation on the proposal for a Regulation on substances of human origin (SoHO)
07/09/2022
07/09/2022
Advanced therapy medicinal products: SMEs call for a better investment environment in Europe
07/09/2022
07/09/2022
Factsheet – Increased regulatory efficiency; what we need for the next generation of medicine
07/09/2022
07/09/2022
Factsheet – European Health Data Space
07/09/2022
07/09/2022
Factsheet – A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare
07/09/2022
07/09/2022
Factsheet – A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe
29/07/2022
29/07/2022
Towards an accurate accounting for carbon from biomass in the Product Environmental Footprint (PEF)
27/07/2022
27/07/2022
EuropaBio position on the European Health Data Space proposal
18/07/2022
18/07/2022
EuropaBio Statement on the proposal for a Regulation on substances of human origin (SoHO)
13/07/2022
13/07/2022
Recombinant DNA in fermentation products is of no regulatory relevance
13/07/2022
13/07/2022
EuropaBio sat down with new Member Phytolon, to learn more about the future of natural food colours
13/07/2022
13/07/2022
Phytolon joins EuropaBio: natural food colours for better health and environmental sustainability
07/07/2022
07/07/2022
EuropaBio Statement on the publication of the New European Innovation Agenda
06/07/2022
06/07/2022
Value of Biotech
29/06/2022
29/06/2022
EuropaBio’s Vision for Europe: Innovation, Investment, Excellence
27/06/2022
27/06/2022
Unlocking the Promise of Gene Therapy
24/06/2022
24/06/2022
Considering microorganisms and New Genomic Techniques: on the need for a new GMO legislation in the European Union
23/06/2022
23/06/2022
DSM’s Patricia Malarkey appointed as new Chair of EuropaBio
20/06/2022
20/06/2022
Seizing opportunities for continued innovation, investment, and excellence in orphan medicines in Europe
15/06/2022
15/06/2022
EFIB 2022 Start-up Village: applications are open!
13/06/2022
13/06/2022
EuropaBio’s Claire Skentelbery elected as new Vice-chair of ICBA
09/06/2022
09/06/2022
EuropaBio Response to the publication of the Bioeconomy Strategy Progress Report
08/06/2022
08/06/2022
EuropaBio participates at the BIO International Convention 2022 in San Diego
25/05/2022
25/05/2022
European Week Against Cancer 2022 – Interview with Santiago Aguirre, Market Lead Europe Oncology, Sanofi
23/05/2022
23/05/2022
Big Changes Start Small
23/05/2022
23/05/2022
Jamie Wilkinson new Healthcare Biotechnology Director at EuropaBio
16/05/2022
16/05/2022
EuropaBio Statement on the Evaluation of the Cross-Border Healthcare Directive
12/05/2022
12/05/2022
A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe
27/04/2022
27/04/2022
EuropaBio SME BioForum: a new voice for the biotechnology SME community in Europe
25/04/2022
25/04/2022
Opinion: A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare
24/04/2022
24/04/2022
EuropaBio published policy recommendations for the healthcare and industrial biotechnology sectors
11/04/2022
11/04/2022
Registration is now open for #EFIB2022: benefit from the early bird fee
05/04/2022
05/04/2022
Become a partner of European Biotech Week 2022
04/04/2022
04/04/2022
EuropaBio NAC Summit 2022: key recommendations on how National associations can deliver Europe’s innovation, investment and excellence in biotechnology
16/03/2022
16/03/2022
EuropaBio response to the Call for Evidence on Soil health – protecting, sustainably managing and restoring EU soils
11/03/2022
11/03/2022
EuropaBio Statement on the Russian Invasion of Ukraine
08/03/2022
08/03/2022
EuropaBio National Associations Council Summit 2022: modernised regulation and legislation will deliver the potential of European biotechnology
28/02/2022
28/02/2022
EuropaBio Statement on Rare Disease Day
22/02/2022
22/02/2022
EuropaBio sat down with new Member Remilk, to learn more about the future of sustainable food production
22/02/2022
22/02/2022
Remilk joins EuropaBio: recreating dairy that makes the world a better place
21/02/2022
21/02/2022
Interview with Claire Skentelbery, Director General, EuropaBio on the 15th Edition of the European Forum for Industrial Biotechnology and the Bioeconomy (EFIB)
17/02/2022
17/02/2022
EuropaBio signs EU Code of Conduct
01/02/2022
01/02/2022
EuropaBio National Associations Council Summit 2022 (French Presidency): how does biotechnology deliver the Industrial strategy across sectors?
31/01/2022
31/01/2022
EuropaBio becomes a partner of a new European partnership for health
24/01/2022
24/01/2022
SAVE THE DATE: EFIB 2022 goes to Vilnius, Lithuania
22/12/2021
22/12/2021
EuropaBio: Revision of the EU general pharmaceuticals legislation for a healthier tomorrow
15/12/2021
15/12/2021
EuropaBio sat down with new member AB Enzymes, to find out about their highly customizable enzymes solutions
15/12/2021
15/12/2021
EuropaBio sat down with new member MabDesign, to find out about its work with the French biopharmaceutical industry
14/12/2021
14/12/2021
AB Enzymes joins EuropaBio: Individual Enzyme Solutions for Individual Requirements
14/12/2021
14/12/2021
MabDesign joins EuropaBio: innovation linked to the industrial field of biotherapy
13/12/2021
13/12/2021
Interview with Ingmar Hoerr, CureVac Founder and holder of the first patents associated with mRNA
01/12/2021
01/12/2021
EuropaBio sat down with new member ProductLife, to find out about their long-term goals Interview with… Xavier Duburcq, CEO at ProductLife Group
01/12/2021
01/12/2021
ProductLife joins EuropaBio: improving human health by delivering regulatory compliance services for the safe and effective use of medical solutions
01/12/2021
01/12/2021
EUBA position on the JRC LCA Methodology
22/11/2021
22/11/2021
The review of the general pharmaceutical legislation: an opportunity that should not be missed?
08/11/2021
08/11/2021
What is the use of innovation if it cannot be implemented? Or why consumers have the last word
03/11/2021
03/11/2021
EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform
03/11/2021
03/11/2021
Olon joins EuropaBio – Quality and Sustainability: A Modern Industrial Vision that Starts from Respect and Protection of the Environment
27/10/2021
27/10/2021
EuropaBio Comments on the Roadmap on a Policy Framework on Biobased, Biodegradable and Compostable Plastics
26/10/2021
26/10/2021
EuropaBio response to the public consultation on the roadmap on Sustainable Food Systems
26/10/2021
26/10/2021
Healthy Planet, Healthy People: a Pathway for Green Transition in the Biopharmaceutical Ecosystem
22/10/2021
22/10/2021
EuropaBio Response to the Inception Impact Assessment for Legislation for Plants Produced from Certain New Genomic Techniques (NGTs)
20/10/2021
20/10/2021
EuropaBio sat down with new Member Puratos, to find out the secret behind their centenary success
20/10/2021
20/10/2021
Puratos joins EuropaBio: Striving to Offer Healthier Solutions Every Day
19/10/2021
19/10/2021
EuropaBio Patient Bio-Forum: challenges and future potential of European Reference Networks
18/10/2021
18/10/2021
European Biotech Week 2021: Telling the stories of European Biotechnology
14/10/2021
14/10/2021
EuropaBio sat down with new Member IFF, to find out about their focus on health and well-being, product performance, and user satisfaction
14/10/2021
14/10/2021
IFF joins EuropaBio: Applying Science and Creativity for a Better World
07/10/2021
07/10/2021
#EFIB2021: Industry sets up the Business vision to deliver Green Deal ambitions
07/10/2021
07/10/2021
EFIB Vienna Statement 2021
06/10/2021
06/10/2021
#EFIB2021: Industrial Biotechnology in the business spotlight for EU Green Deal
04/10/2021
04/10/2021
EuropaBio Comments on the Roadmap on Restoring Sustainable Carbon Cycles
30/09/2021
30/09/2021
Artificial intelligence: investing in new technologies in healthcare
27/09/2021
27/09/2021
Europe celebrates life science with European Biotech Week 2021
08/09/2021
08/09/2021
Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies
27/08/2021
27/08/2021
EuropaBio response to the Public consultation on European bioeconomy policy: stocktaking and future developments
10/08/2021
10/08/2021
EuropaBio comments on the public consultation on blue bioeconomy
02/08/2021
02/08/2021
EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics
29/07/2021
29/07/2021
EuropaBio response to the Public Consultation ‘Digital Health Data and Services – The European Health Data Space’
26/07/2021
26/07/2021
EuropaBio response to the European Commission Public Consultation on the Regulation for Orphan Medicinal Products and Paediatrics: the value brought by the technology to patients and society should be well recognised
22/07/2021
22/07/2021
Call for tender: EuropaBio requires Maintenance and Development Services for its four Websites
20/07/2021
20/07/2021
EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare
03/07/2021
03/07/2021
EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years
29/06/2021
29/06/2021
A Declaration from Members of the World’s Biotechnology Sector On Global Access to COVID Vaccines & Treatments and the Role of Intellectual Property
29/06/2021
29/06/2021
EV Biotech joins EuropaBio: effective, bio-based alternatives to conventional chemical-synthetic production processes
23/06/2021
23/06/2021
Interview with… Dr. Jernej Pintar, CEO and Head of Tech Community at Technology Park Ljubljana
23/06/2021
23/06/2021
Technology Park Ljubljana joins EuropaBio: better world through better technology
16/06/2021
16/06/2021
EPSCO Council conclusions: EuropaBio calls for more pragmatic approach addressing access, availability and affordability of medicines
14/06/2021
14/06/2021
European Biotech Week 2021: EuropaBio invites national biotech communities to celebrate science and innovation
14/06/2021
14/06/2021
Novartis is proud to support the EuropaBio 25th Anniversary
09/06/2021
09/06/2021
Interview with Cyrille Pauthenier, CEO of Abolis Biotechnologies – The Bio-Synthesis Architects
07/06/2021
07/06/2021
EuropaBio invited healthcare biotech SMEs to learn about EU Policy Priorities
07/06/2021
07/06/2021
Pragmatic IP solutions and strong collaborations will ensure faster global access to vaccines
01/06/2021
01/06/2021
EFIB 2021 launch event: biotech community discussed innovation solutions for a sustainable future
31/05/2021
31/05/2021
EuropaBio Key Messages to 94th Pharmaceutical Committee – 28 May 2021
27/05/2021
27/05/2021
EuropaBio welcomes the EU strategy on Covid-19 therapeutics
27/05/2021
27/05/2021
EuropaBio meets EMA to exchange views on topics of common interest
26/05/2021
26/05/2021
Enabling NGT products to contribute to sustainability: The role of Industrial Biotechnology
26/05/2021
26/05/2021
Inter-association letter to the EU Ministers of Agriculture and DG SANTE
25/05/2021
25/05/2021
Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO Legislation
20/05/2021
20/05/2021
EuropaBio Patient BioForum: Advancing Patient Access to Innovative Treatments
20/05/2021
20/05/2021
Decentralised clinical trials, the future of clinical research
20/05/2021
20/05/2021
Advanced Therapies bring tranformational value to European patients
19/05/2021
19/05/2021
EFIB 2021 ’Delivering the EU Green Deal: Industrial biotechnology into business’: Registration is Open
18/05/2021
18/05/2021
Interview with Bill Nankervis, Executive Vice President and Chief Operating Officer, Lallemand Group of Companies
18/05/2021
18/05/2021
Lallemand joins EuropaBio: new global opportunities for industrial biotechnology
12/05/2021
12/05/2021
EuropaBio celebrated its inaugural National Associations Council Summit: Collaborations and trust are vital to build a responsive and competetive biotech sector in Europe
12/05/2021
12/05/2021
Meatable joins EuropaBio: together towards a more sustainable food industry
12/05/2021
12/05/2021
Interview with… Krijn de Nood, Co-Founder & CEO at Meatable
07/05/2021
07/05/2021
IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge
06/05/2021
06/05/2021
EU Industrial Strategy 2020: EuropaBio welcomes increased focus on competitiveness and resilience, driven by innovation and advanced technologies
05/05/2021
05/05/2021
EuropaBio comments on the designation of official laboratories for animal and plant health and safe food and feedstuffs
05/05/2021
05/05/2021
EuropaBio comments on the new EU soil strategy
05/05/2021
05/05/2021
EUBA Statement on Revised draft Delegated Act on climate-related objectives
04/05/2021
04/05/2021
Interview with… Juan Medina, Co-Founder & CEO at Kaffe Bueno
04/05/2021
04/05/2021
Kaffe Bueno joins EuropaBio: unlocking coffee’s therapeutic and industrial potential
03/05/2021
03/05/2021
EuropaBio launches a new Biopharmaceutical Strategy Group
29/04/2021
29/04/2021
EuropaBio on NGT study: A positive step towards delivering innovation
28/04/2021
28/04/2021
Interview with… Agne Vaitkeviciene, Executive Director of LBTA
28/04/2021
28/04/2021
The Lithuanian Biotechnology Association joins EuropaBio: it’s time to put Lithuania on a map of the most biotech savvy nations
27/04/2021
27/04/2021
EuropaBio proposes how to increase competitiveness of biotechnology sector in the EU
25/04/2021
25/04/2021
EuropaBio invited industrial biotech SMEs to learn about EU Policy Priorities
21/04/2021
21/04/2021
Interview with… Kristina Eskenazi, Chair of Health & Life Sciences Cluster Bulgaria
21/04/2021
21/04/2021
Health and Life Sciences Cluster Bulgaria joins EuropaBio: AI as enabler of biotech growth
16/04/2021
16/04/2021
Online Roundtable Report: An EU Vision For Life Science and Biotechnology for a Healthy and Sustainable EU
16/04/2021
16/04/2021
EuropaBio Response to the Public Consultation on Blood, tissues and cells for medical treatments & therapies
14/04/2021
14/04/2021
Interview with… Dr. Kim Domela Kjøller, CEO at UNION Therapeutics
14/04/2021
14/04/2021
UNION Therapeutics joins EuropaBio: building a pipeline for inflammation and infectious diseases
06/04/2021
06/04/2021
Interview with… Dr. Jim Lalonde, Head of Microbial Business Area at INSCRIPTA
06/04/2021
06/04/2021
Inscripta joins EuropaBio: delivering global biotechnology advances
31/03/2021
31/03/2021
EuropaBio response to the EGE report ‘Ethics of Genome Editing’
29/03/2021
29/03/2021
Abolis joins the EuropaBio 25th Anniversary in 2021
25/03/2021
25/03/2021
EuropaBio Statement – Vaccine production scale up: International collaboration remains the key
22/03/2021
22/03/2021
EuropaBio and P-BIO launch the National Associations Council Summit 2021 – Building on Biotechnology: from vaccines to Economic Growth for Europe
15/03/2021
15/03/2021
Abolis joins EuropaBio: Sustainable Bio-Based Products
09/03/2021
09/03/2021
Catalent joins the EuropaBio 25th Anniversary in 2021
05/03/2021
05/03/2021
Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe
01/03/2021
01/03/2021
Rare Disease Week 2021 – Interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi
01/03/2021
01/03/2021
EuropaBio Celebrates 25 Years of Biotech Innovation with 2021 Anniversary Programme
24/02/2021
24/02/2021
European Health Emergency Preparedness and Response Authority (HERA) Consultation – EuropaBio’s Feedback
15/02/2021
15/02/2021
The Business of Biotechnology: Growing for Europe’s tomorrow
12/02/2021
12/02/2021
EuropaBio and Alexion: RARE Conversations (Take Two) Keeping Rare Disease Patients In The Centre Of Discussion
12/02/2021
12/02/2021
EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare
04/02/2021
04/02/2021
EuropaBio draft response to the IIA on European Health Data Space
02/02/2021
02/02/2021
Measuring the economic footprint of the Biotechnology Industry in Europe (WifOR Study)
29/01/2021
29/01/2021
Building a European Health Union
28/01/2021
28/01/2021
European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation
20/01/2021
20/01/2021
Revision of the EU legislation on medicines for children and rare diseases
24/12/2020
24/12/2020
Joint Statement: Comitology Reform Threatens Innovation
20/12/2020
20/12/2020
EuropaBio Comments on the Draft Delegated Act on Climate-Related Objectives under the Taxonomy Regulation
30/11/2020
30/11/2020
Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms
25/11/2020
25/11/2020
An EU IP Action Plan for strong industrial ecosystems
25/11/2020
25/11/2020
EuropaBio Statement on the EU Pharmaceutical Strategy
10/11/2020
10/11/2020
Create sustainable bio-based and biodegradable plastics
02/11/2020
02/11/2020
EuropaBio announces Dr. Claire Skentelbery as new Director General of the Association
20/10/2020
20/10/2020
EuropaBio on Use of Real-World Data (RWD) and Real-World Evidence (RWE) for regulatory decision-making
19/10/2020
19/10/2020
Application of the ATMP Hospital Exemption in the EU
07/10/2020
07/10/2020
Nobel Prize for Genome Editing Pioneers
02/10/2020
02/10/2020
#EFIB2020 goes digital – EuropaBio hosts 13th annual European Industrial Biotechnology and Bioeconomy Conference
30/09/2020
30/09/2020
EuropaBio Patient engagement with the European Medicines Agency
24/09/2020
24/09/2020
Genome editing FAQ
03/09/2020
03/09/2020
Novartis’s Andrew Topen appointed as new Chairman of EuropaBio
24/08/2020
24/08/2020
Genome-Edited Products and Projects: Resources and Examples
13/08/2020
13/08/2020
Statement in response to the publication of the European Commission’s evaluation of the Orphan and Paediatric Regulations
03/08/2020
03/08/2020
Joint Statement on the Health Innovation Partnership Proposal
30/07/2020
30/07/2020
Joint response of EuropaBio and BIO on the EU Data Strategy Consultation
30/07/2020
30/07/2020
EuropaBio response to the public consultation on the Roadmap for an EU Pharmaceutical Strategy
30/07/2020
30/07/2020
EuropaBio response to the Work Programme of the eHealth Stakeholder Group
15/07/2020
15/07/2020
EuropaBio position paper on the Farm to Fork Strategy
30/06/2020
30/06/2020
EuropaBio observations in response to Europe’s Beating Cancer Plan
22/06/2020
22/06/2020
EuropaBio position on the EU Biodiversity Strategy for 2030
19/06/2020
19/06/2020
ACCELERATE FAIR Initiative Letter of Support
17/06/2020
17/06/2020
EU-UK Future Relations – Joint Letter Life Sciences Coalition
26/05/2020
26/05/2020
Joint statement on the EU Climate Law
20/05/2020
20/05/2020
The impact of COVID-19 on patients with chronic or life-threatening conditions
20/05/2020
20/05/2020
EuropaBio position on Germline Genome Editing
20/05/2020
20/05/2020
EuropaBio highlights synergies between biotechnology and Farm to Fork and Biodiversity Strategy ambitions
30/04/2020
30/04/2020
How soon can we respond to COVID-19?
30/04/2020
30/04/2020
EuropaBio reply letter to European Patients’ Forum’s call on COVID-19
30/04/2020
30/04/2020
CRISPR and Coronavirus
30/04/2020
30/04/2020
Clinical Trials and Coronavirus
30/04/2020
30/04/2020
World Haemophilia Day – Interview with Amanda Bok (EHC)
29/04/2020
29/04/2020
European Bioeconomy Alliance (EUBA) Position on the EU Green Deal
28/04/2020
28/04/2020
Primary Immunodeficiencies Week – Interview Johan Prevot (IPOPI)
17/04/2020
17/04/2020
World Haemophilia Day – Interview with Dr. Ian Winburn (Pfizer)
17/04/2020
17/04/2020
World Haemophilia Day – A Message from Paul Perrault (CSL Behring)
17/04/2020
17/04/2020
World Haemophilia Week – Interview with Philip Wood (Sobi)
10/04/2020
10/04/2020
European Industry trade and supply chain needs to respond to Covid-19 – Joint Letter to the EU Trade Ministers
30/03/2020
30/03/2020
Biotechnology spearheads the fight against COVID-19
09/03/2020
09/03/2020
EuropaBio Position & Policy Recommendations to support EU ATMP Innovation
29/02/2020
29/02/2020
Strike Rare Diseases at the Root!
12/02/2020
12/02/2020
European Bioeconomy Alliance (EUBA) comments on the European Climate Law Roadmap
12/02/2020
12/02/2020
Industrial biotechnology solutions for sustainable agriculture
04/02/2020
04/02/2020
Let’s Beat Cancer with Innovation!
01/02/2020
01/02/2020
What if we used biology instead of chemistry for manufacturing?
30/01/2020
30/01/2020
A Vision for a EU Life Science and Biotechnology Strategy
26/01/2020
26/01/2020
What if we could definitively cure AIDS
25/01/2020
25/01/2020
Create immunotherapy treatments for cancer
25/01/2020
25/01/2020
Reduce the depletion of small fish in our oceans
20/01/2020
20/01/2020
EuropaBio comments on the Circular Economy Action Plan
20/01/2020
20/01/2020
What if we used algae to make biofuel?
15/01/2020
15/01/2020
Create ‘living drugs’ that treat cancer
15/01/2020
15/01/2020
What if we could heal sick blood cells
10/01/2020
10/01/2020
What if we could find new tools in the fight against cancer
09/01/2020
09/01/2020
Inter-association letter to the European Commission and Member States
05/01/2020
05/01/2020
What if we could transform wood into food preservatives?
01/01/2020
01/01/2020
What if we could prevent childhood blindness
30/11/2019
30/11/2019
EuropaBio position on Germline Genome Editing
10/10/2019
10/10/2019
EuropaBio Patients BioForum – Key Messages
10/10/2019
10/10/2019
Wealth of innovation on display & bio-based winners revealed at EFIB 2019 in Brussels
30/09/2019
30/09/2019
#EFIB2019 – EuropaBio hosts 12th annual Industrial Biotech and Bioeconomy Conference
26/09/2019
26/09/2019
Industrial Biotechnology – Enabling a Circular Bioeconomy in Europe
16/09/2019
16/09/2019
Joint Statement for an Ambitious Horizon Europe Programme
30/06/2019
30/06/2019
EuropaBio Healthcare Manifesto
25/06/2019
25/06/2019
Achieving the Potential of Genome Editing: the Perspective of the European Biotech Industry
03/06/2019
03/06/2019
Vision for a Circular Bio-Society
09/05/2019
09/05/2019
Open Letter to Member States on the EU Court Ruling on Mutagenesis
20/04/2019
20/04/2019
Joint Statement on Horizon Europe
28/02/2019
28/02/2019
EuropaBio Advanced Therapy
20/02/2019
20/02/2019
Export Manufacturing Waiver for Supplementary Protection Certificates: a red flag for investment in EU healthcare biotech
19/02/2019
19/02/2019
Advanced Medicinal Therapies – Step Up The Healthcare Revolution Now
20/12/2018
20/12/2018
Case Studies demonstrating Industrial Biotech contribution to UN SDGs
29/11/2018
29/11/2018
Statement: As EU court ruling risks blocking innovation, the European biotech industry calls for science-based political decision making on genome edited products
23/11/2018
23/11/2018
Joint Statement on HE and Partnerships
16/10/2018
16/10/2018
#EFIB2018 – Toulouse hosts 11th edition of leading Industrial Biotech Conference highlighting the breakthroughs and potential of the circular bioeconomy
11/10/2018
11/10/2018
EuropaBio welcomes renewed commitment to the EU Bioeconomy
29/06/2018
29/06/2018
Chemically Synthesized Proteins Referencing Biological Medicinal Products
28/06/2018
28/06/2018
Joint Pharmaceutical Industry Statement on the Commission’s Proposal for a Regulation on Health Technology Assessment (HTA)
25/06/2018
25/06/2018
Industrial biotechnology – Contributing towards achieving the UN global Sustainable Development Goals
28/05/2018
28/05/2018
SPC waiver risks downgrading the EU as a hub for Health Innovation
25/05/2018
25/05/2018
EFIB 2018 Registrations are now open
31/03/2018
31/03/2018
Statement in response to the EU Council ratifying the Brexit transition deal
31/03/2018
31/03/2018
European health community issues key questions Article 50 negotiations must answer for patients and public health
28/12/2017
28/12/2017
United Kingdom Exiting from EU – BREXIT. Life Sciences Industry CoalitionUK Exiting from EU – Life Sciences Industry Coalition
28/12/2017
28/12/2017
BREXIT Life Sciences Coalition – Joint Position Paper
29/11/2017
29/11/2017
European Commission launches: “What I need to know about Biosimilar Medicines – Information for patients”, in 23 EU languages
30/10/2017
30/10/2017
MetGen receives John Sime Award and Plantics becomes PitchFest winner at #EFIB2018
28/10/2017
28/10/2017
From Patent to Patient – The importance of IP rewards and incentives
27/09/2017
27/09/2017
Joint Press Release on ATMPs and GMOs in Europe
06/06/2017
06/06/2017
EuropaBio launches recommendations to enhance transparency of biosimilar labels
27/05/2017
27/05/2017
Biosimilar SmPC Recommendations
03/03/2017
03/03/2017
EuropaBio statement on European Parliament report on EU options for improving access to medicines
02/02/2017
02/02/2017
“Buying Innovative” in the Healthcare Biotech Market in Europe
23/01/2017
23/01/2017
European Commission Initiative Improves Information for Patients on Biosimilar Medicines
25/09/2016
25/09/2016
Jobs & Growth Generated by Industrial Biotechnology in Europe
26/10/2015
26/10/2015
Bioeconomy Factsheets
 

BIOTECH NEWSLETTER

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!

Subscribe

FOLLOW US HERE

Keep up with what is happening in the Biotech sector by connecting with us on social media!

facebook
twitter
instagram
linkedin
youtube
 

BIOTECH NEWSLETTER

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!

Subscribe